Vanda Pharmaceuticals
VNDA
VNDA
140 hedge funds and large institutions have $672M invested in Vanda Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
22% more funds holding
Funds holding: 115 → 140 (+25)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
140
Holding in Top 10
4
Calls
$27M
Puts
$17.2M
Top Buyers
| 1 | +$20.7M | |
| 2 | +$16.7M | |
| 3 | +$11.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.03M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$8.8M |
Top Sellers
| 1 | -$42.6M | |
| 2 | -$29.6M | |
| 3 | -$28.1M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$9.08M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$5.19M |